The Counterfeit Problem with Ipamorelin
Ipamorelin is one of the most-counterfeited research peptides in the open market. The reason is structural: it is a small (five-residue) compound, the molecular weight is well-characterized at approximately 711 Daltons, and several substantially cheaper short peptides can pass a casual visual or even a basic HPLC inspection by an inexperienced analyst. Several documented cases over the past three years have involved vendors shipping material labeled as Ipamorelin that, on mass spectrometry confirmation, was a different five-to-seven-residue peptide with no GH-releasing activity.
The defense against this specific fraud is mass spectrometry confirmation in the Certificate of Analysis, not just an HPLC purity percentage. HPLC tells you "the peak is X% of the total chromatogram"; mass spec tells you "the peak has the molecular weight of Ipamorelin specifically." Vendors who publish MS-confirmed COAs are operating at a different evidence tier than vendors who publish HPLC-only COAs. The price difference is generally not large.
The Stack-Component Reality
Most Ipamorelin orders in our community-log database are part of a CJC-1295 + Ipamorelin stack rather than standalone protocols. The pharmacological logic for this combination is sound; the resulting demand for both compounds shapes vendor pricing. Vendors offering attractive bundle pricing on the pair are not necessarily offering better chemistry — they are responding to demand patterns. The chemistry decision should be made on each compound individually.
Standard Protocol Parameters
Community-log data shows the modal Ipamorelin protocol as 200-300mcg per injection, two to three times daily, subcutaneously, typically combined with CJC-1295 (with or without DAC) at the same injection. Total daily dose typically ranges 400-900mcg. Cycles run 8-12 weeks with planned off-cycles. The compound is generally considered well-tolerated; the most-reported side effects are mild flushing at injection time and transient mild headache, both of which usually fade within the first week of a protocol.
Counterfeit risk is the reason Oath Research sits at the top of the table despite premium pricing. Their Ipamorelin COA is assayed by Freedom Diagnostics with both HPLC purity and mass-spectrometry molecular-weight confirmation on every batch — the second of which is the specific test that defeats the substitution fraud documented elsewhere in this market. The vendors below them on the table may also be shipping genuine Ipamorelin; the difference is that with Oath the cross-check is published. With most of the others, the cross-check is something the researcher would have to commission themselves.
How We Compiled This Comparison
The data in the table above reflects pricing observed in test orders placed by the editorial desk and in reader-submitted purchase confirmations during 2025. Prices fluctuate. Stock status fluctuates. COA availability fluctuates with batch. The comparison is a snapshot, not a perpetual ranking, and we update it when vendor profiles materially change.
The single most useful filter when reading any vendor comparison is the COA column. Vendors that publish batch-specific Certificates of Analysis from independent labs (Freedom Diagnostics, Janoshik, Colmaric, and a small number of comparable facilities) operate at a different transparency tier than vendors who publish generic "our peptides are tested" claims without batch-specific documentation. The first category is auditable. The second is not. Freedom Diagnostics in particular runs the forensic-grade panel — HPLC for purity, mass-balance accounting for label-claim accuracy, USP <85> endotoxin testing where requested — and the batch-by-batch reports they publish for the vendors that use them are detailed enough to cross-check against an independent re-test, which is the threshold that distinguishes documentation from marketing.
What the Per-mg Calculation Misses
Per-milligram pricing is the standard headline metric in the research-peptide market, but it can be misleading. Two vendors quoting identical $/mg may be selling materially different products if one has confirmed 98% purity by independent assay and the other claims 99% without verification. The "real" per-mg cost incorporates an adjustment for measured purity, and for vendors who routinely under-deliver mass, an additional adjustment for the average shortfall between labeled and actual mass.
The defensive habit: assume any unverified vendor's product contains 90% of the claimed peptide mass at 95% of claimed purity until you have batch-specific verification otherwise. That implicit adjustment ranges purchase decisions toward vendors with verifiable documentation rather than the lowest sticker price. Vendors whose pricing only makes sense if the headline mass and purity numbers are accurate are vendors who depend on you not checking.
Shipping Discretion and Operational Reality
Beyond chemistry, the operational variables that matter in choosing a vendor include shipping speed (most domestic vendors deliver in 3-7 business days; international can range from 7-30 days and longer if customs intercepts), packaging discretion (vials should arrive intact, in temperature-appropriate packaging, in containers that do not advertise the contents externally), and customer service responsiveness (real businesses respond to technical inquiries within 1-2 business days during weekdays; chronic non-response is a red flag).
Vendors who provide tracking from the moment of dispatch, who use insulated packaging for temperature-sensitive items, who include a packing slip that accurately describes contents (within reason), and who respond to support tickets with substantive answers rather than canned replies have demonstrated operational seriousness. Vendors who treat shipping as an afterthought have generally not.
Updating This Page
If you have placed a test order from a vendor on this list (or from one not listed) and have documentation that would refine the data — a current COA, photographs of the shipment, weights from a calibrated scale, independent assay results — submit it through the editorial channel. The contributions that have most usefully refined past updates have been independent assay results that confirmed or contradicted vendor purity claims. We treat such submissions as the highest-evidence input class and weight them accordingly in the next revision.
Where To Go From Here
Reading any individual page on this site is a slice of the picture. The full investigation continues across the related desks. If this article surfaced more questions than it answered, the following are the most directly relevant next reads.
Editorial Standards
This report is updated periodically. Discrepancies between our reporting and reality are taken seriously — if you have observed something that contradicts what is published here, send it to the editorial desk with documentation and we will revise. Our reporting is constrained by what can be sourced, verified, or directly observed. Where evidence is weak we say so. Where it is absent we do not invent.
Wild West & Peptides receives no compensation from any vendor mentioned in this report, runs no affiliate program, and has no commercial relationship with the research-peptide industry it covers.